Physician profile
Michael D Sather
NPI 1235358144
$11,106.56
in general payments reported to CMS, 2019-2025
15 companies · $295 in 2025
The $295 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,592 · 2020: $1,166 · 2021: $3,785 · 2022: $242 · 2023: $819 · 2024: $209 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $750 · Food and Beverage: $573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $750.00 |
| Food and Beverage | $572.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineology INC. | $5,150.66 | 2019-2025 | |
| Boston Scientific Corporation | $2,431.23 | 2019-2023 | |
| Livanova USA, INC. | $1,756.00 | 2021 | |
| Medtronic USA, INC. | $756.99 | 2019-2020 | |
| Medtronic, INC. | $254.82 | 2021-2025 | Inceptiv, Intellis Adaptivestim |
| Neuropace, INC. | $216.30 | 2019-2024 | |
| Nevro Corp. | $139.33 | 2019-2021 | |
| Microtransponder, INC. | $84.29 | 2025 | |
| Getset Surgical INC | $68.85 | 2023 | Goplf! Posterior Lateral Fusion System |
| Zimmer Biomet Holdings, INC. | $63.84 | 2019 | |
| Grt US Holding, INC. | $49.58 | 2022 | |
| Abbott Laboratories | $40.91 | 2020 | |
| Globus Medical, INC. | $38.22 | 2024 | Mars 3v/3vl, Elsa |
| Medical Device Business Services, INC. | $34.36 | 2025 | Teligen |
| Baxter Healthcare | $21.18 | 2024 | Floseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sather listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.